WHWK
Whitehawk Therapeutics, Inc.
Price Chart
Latest Quote
$4.15
-0.25 (-5.68%)
Current Price
| Previous Close | $4.40 |
| Open | $4.39 |
| Day High | $4.51 |
| Day Low | $4.10 |
| Volume | 124,460 |
Stock Information
| Shares Outstanding | 49.45M |
| Cash Equivalents | $123.04M |
| Net Income | $-115.81M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $205.23M |
| EPS (TTM) | $-2.49 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $82.18M |
| Income | $-115.81M |
| Book/sh | $2.89 |
| Cash/sh | $2.49 |
| Employees | 23 |
Financial Ratios
| Quick Ratio | 11.13 |
| Current Ratio | 11.36 |
Returns & Margins
| ROA | -42.46% |
| ROE | -68.54% |
Ownership
| Insider Ownership | 13.41% |
| Institutional Ownership | 72.46% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -3.10 |
| P/B | 1.44 |
Analyst Data
| Recommendation | buy |
| Target Price | $6.50 |
Technical Indicators
| SMA20 | $4.42 |
| SMA50 | $4.07 |
| SMA200 | $2.91 |
| RSI | 38.59 |
| ATR | 0.3611 |
| Shares Float | 18.04M |
| Short Float | 3.08% |
| Short Ratio | 2.02 |
| Volatility | 0.77 |
| Rel Volume | 0.24 |
Performance History
| Week | -12.08% |
| Month | +0.00% |
| Quarter | +10.67% |
| 6 Months | +85.27% |
| YTD | +70.08% |
| Year | +145.56% |
| 3 Years | -48.12% |
| 5 Years | -83.73% |
| 10 Years | -93.85% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $4.15 | 124,500 |
| 2026-06-04 | $4.40 | 196,200 |
| 2026-06-03 | $4.34 | 168,400 |
| 2026-06-02 | $4.18 | 218,200 |
| 2026-06-01 | $4.49 | 291,000 |
| 2026-05-29 | $4.72 | 220,400 |
| 2026-05-28 | $4.78 | 259,000 |
| 2026-05-27 | $4.78 | 371,200 |
| 2026-05-26 | $4.77 | 1,013,900 |
| 2026-05-22 | $4.49 | 347,100 |
| 2026-05-21 | $4.30 | 164,900 |
| 2026-05-20 | $4.22 | 167,700 |
| 2026-05-19 | $4.07 | 239,400 |
| 2026-05-18 | $4.25 | 294,500 |
| 2026-05-15 | $4.70 | 245,300 |
| 2026-05-14 | $5.10 | 391,200 |
| 2026-05-13 | $4.93 | 5,277,100 |
| 2026-05-12 | $3.92 | 56,500 |
| 2026-05-11 | $3.80 | 204,300 |
| 2026-05-08 | $3.97 | 54,000 |
| 2026-05-07 | $3.94 | 136,400 |
| 2026-05-06 | $4.15 | 147,200 |
About Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
đ° Latest News
Acuta Capital Sells 56% of Ocular Therapeutix Shares in Q1
Motley Fool âĸ 2026-05-26T22:26:41Z
WHWK Stock Edges Up After Hours: Firm Boosts Pipeline Of Cancer Drugs On The Heels Of Capital Raise
Stocktwits âĸ 2026-05-22T00:38:02Z
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy
Motley Fool âĸ 2026-05-16T15:01:01Z
May 2026's Promising Penny Stocks
Simply Wall St. âĸ 2026-05-14T12:04:54Z
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga âĸ 2026-05-13T17:06:16Z
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga âĸ 2026-05-13T12:06:16Z
Discovering Whitehawk Therapeutics Among 3 Promising Penny Stocks
Simply Wall St. âĸ 2026-04-15T12:05:27Z
Aadi Bioscience Conference: Whitehawk Unveils 3-Program ADC Pipeline, Targets First Data in 2027
MarketBeat âĸ 2026-03-10T17:55:38Z
Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy?
Zacks âĸ 2026-02-18T14:41:00Z
Tempus AI's Key 2025 Milestones Continue to Gain Industry Attention
Zacks âĸ 2026-01-21T12:57:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $760,000 | $3,024,000 | $2,809,000 | $1,335,000 |
| Cost Of Revenue | $760,000 | $3,024,000 | $2,809,000 | $1,335,000 |
| Total Revenue | $7,145,000 | $25,983,000 | $24,354,000 | $15,216,000 |
| Operating Revenue | $7,145,000 | $25,983,000 | $24,354,000 | $15,216,000 |
| Expenses | ||||
| Interest Expense | $0 | $154,000 | $231,000 | $230,000 |
| Total Expenses | $121,545,000 | $90,803,000 | $96,287,000 | $74,173,000 |
| Other Income Expense | $87,573,000 | $-2,642,000 | $-1,000 | $-3,724,000 |
| Other Non Operating Income Expenses | $302,000 | - | - | - |
| Net Non Operating Interest Income Expense | $6,231,000 | $3,771,000 | $6,169,000 | $2,168,000 |
| Interest Expense Non Operating | $0 | $154,000 | $231,000 | $230,000 |
| Operating Expense | $120,785,000 | $87,779,000 | $93,478,000 | $72,838,000 |
| Other Operating Expenses | - | - | - | - |
| General And Administrative Expense | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-20,596,000 | $-63,691,000 | $-65,765,000 | $-60,513,000 |
| Net Interest Income | $6,231,000 | $3,771,000 | $6,169,000 | $2,168,000 |
| Interest Income | $6,231,000 | $3,925,000 | $6,400,000 | $2,398,000 |
| Normalized Income | $-107,867,000 | $-61,049,000 | $-65,764,000 | $-56,789,000 |
| Net Income From Continuing And Discontinued Operation | $-20,596,000 | $-63,691,000 | $-65,765,000 | $-60,513,000 |
| Total Operating Income As Reported | $-114,400,000 | $-67,458,000 | $-71,933,000 | $-62,681,000 |
| Net Income Common Stockholders | $-20,596,000 | $-63,691,000 | $-65,765,000 | $-60,513,000 |
| Net Income | $-20,596,000 | $-63,691,000 | $-65,765,000 | $-60,513,000 |
| Net Income Including Noncontrolling Interests | $-20,596,000 | $-63,691,000 | $-65,765,000 | $-60,513,000 |
| Net Income Continuous Operations | $-20,596,000 | $-63,691,000 | $-65,765,000 | $-60,513,000 |
| Pretax Income | $-20,596,000 | $-63,691,000 | $-65,765,000 | $-60,513,000 |
| Special Income Charges | $87,266,000 | $-2,638,000 | $0 | $-3,724,000 |
| Interest Income Non Operating | $6,231,000 | $3,925,000 | $6,400,000 | $2,398,000 |
| Operating Income | $-114,400,000 | $-64,820,000 | $-71,933,000 | $-58,957,000 |
| Gross Profit | $6,385,000 | $22,959,000 | $21,545,000 | $13,881,000 |
| Per Share | ||||
| Diluted EPS | $-0.33 | $-2.36 | $-2.44 | $-2.69 |
| Basic EPS | $-0.33 | $-2.36 | $-2.44 | $-2.69 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-107,788,000 | $-60,702,000 | $-65,364,000 | $-56,400,000 |
| Total Unusual Items | $87,271,000 | $-2,642,000 | $-1,000 | $-3,724,000 |
| Total Unusual Items Excluding Goodwill | $87,271,000 | $-2,642,000 | $-1,000 | $-3,724,000 |
| Reconciled Depreciation | $79,000 | $193,000 | $169,000 | $159,000 |
| EBITDA (Bullshit earnings) | $-20,517,000 | $-63,344,000 | $-65,365,000 | $-60,124,000 |
| EBIT | $-20,596,000 | $-63,537,000 | $-65,534,000 | $-60,283,000 |
| Diluted Average Shares | $61,886,765 | $27,029,942 | $26,917,967 | $22,511,237 |
| Basic Average Shares | $61,886,765 | $27,029,942 | $26,917,967 | $22,511,237 |
| Diluted NI Availto Com Stockholders | $-20,596,000 | $-63,691,000 | $-65,765,000 | $-60,513,000 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Gain On Sale Of Business | $87,266,000 | $0 | - | - |
| Restructuring And Mergern Acquisition | $0 | $2,638,000 | $0 | - |
| Gain On Sale Of Security | $5,000 | $-4,000 | $-1,000 | - |
| Research And Development | $90,963,000 | $51,030,000 | $48,929,000 | $32,662,000 |
| Selling General And Administration | $29,822,000 | $36,749,000 | $44,549,000 | $40,176,000 |
| Impairment Of Capital Assets | - | - | $0 | $3,724,000 |
| Preferred Stock Dividends | - | - | - | - |
| Other Special Charges | - | - | - | - |
| Other Gand A | - | - | - | - |
Fetched: 2026-05-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $136,311,000 | $52,478,000 | $105,195,000 | $158,378,000 |
| Total Assets | $150,830,000 | $70,319,000 | $132,423,000 | $184,237,000 |
| Total Non Current Assets | $1,817,000 | $9,032,000 | $7,837,000 | $4,208,000 |
| Other Non Current Assets | $1,814,000 | $1,399,000 | $1,866,000 | $2,178,000 |
| Current Assets | $149,013,000 | $61,287,000 | $124,586,000 | $180,029,000 |
| Other Current Assets | $3,316,000 | $2,836,000 | $3,826,000 | $3,746,000 |
| Inventory | $0 | $5,311,000 | $6,427,000 | $1,861,000 |
| Receivables | $0 | $5,903,000 | $5,488,000 | $1,862,000 |
| Accounts Receivable | $0 | $5,903,000 | $5,488,000 | $1,862,000 |
| Cash Cash Equivalents And Short Term Investments | $145,697,000 | $47,237,000 | $108,845,000 | $172,560,000 |
| Cash And Cash Equivalents | $37,568,000 | $28,670,000 | $62,888,000 | $39,019,000 |
| Allowance For Doubtful Accounts Receivable | - | $-100,000 | $-200,000 | - |
| Gross Accounts Receivable | - | $6,003,000 | $5,688,000 | - |
| Goodwill And Other Intangible Assets | - | - | - | $0 |
| Other Intangible Assets | - | - | - | - |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $0 | $833,000 | $1,267,000 | $1,661,000 |
| Long Term Debt And Capital Lease Obligation | $0 | $565,000 | $833,000 | $1,267,000 |
| Current Debt And Capital Lease Obligation | - | $268,000 | $434,000 | $394,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $14,519,000 | $17,841,000 | $27,228,000 | $25,859,000 |
| Total Non Current Liabilities Net Minority Interest | $0 | $767,000 | $833,000 | $7,024,000 |
| Current Liabilities | $14,519,000 | $17,074,000 | $26,395,000 | $18,835,000 |
| Payables And Accrued Expenses | $11,359,000 | $16,742,000 | $22,880,000 | $12,978,000 |
| Payables | $917,000 | $2,159,000 | $11,655,000 | $3,519,000 |
| Accounts Payable | $917,000 | $2,159,000 | $5,898,000 | $3,519,000 |
| Other Non Current Liabilities | - | $202,000 | - | - |
| Tradeand Other Payables Non Current | - | - | $0 | $0 |
| Other Payable | - | - | $5,757,000 | - |
| Equity | ||||
| Common Stock Equity | $136,311,000 | $52,478,000 | $105,195,000 | $158,378,000 |
| Total Equity Gross Minority Interest | $136,311,000 | $52,478,000 | $105,195,000 | $158,378,000 |
| Stockholders Equity | $136,311,000 | $52,478,000 | $105,195,000 | $158,378,000 |
| Gains Losses Not Affecting Retained Earnings | $120,000 | $16,000 | $27,000 | $-115,000 |
| Other Equity Adjustments | $120,000 | $16,000 | $27,000 | $-115,000 |
| Retained Earnings | $-353,250,000 | $-332,654,000 | $-268,963,000 | $-203,198,000 |
| Other | ||||
| Ordinary Shares Number | $47,145,719 | $24,680,708 | $24,554,205 | $24,435,007 |
| Share Issued | $47,145,719 | $24,680,708 | $24,554,205 | $24,435,007 |
| Tangible Book Value | $136,311,000 | $52,478,000 | $105,195,000 | $158,378,000 |
| Invested Capital | $136,311,000 | $52,478,000 | $105,195,000 | $158,378,000 |
| Working Capital | $134,494,000 | $44,213,000 | $98,191,000 | $161,194,000 |
| Capital Lease Obligations | $0 | $833,000 | $1,267,000 | $1,661,000 |
| Total Capitalization | $136,311,000 | $52,478,000 | $105,195,000 | $158,378,000 |
| Additional Paid In Capital | $489,437,000 | $385,114,000 | $374,129,000 | $361,689,000 |
| Capital Stock | $4,000 | $2,000 | $2,000 | $2,000 |
| Common Stock | $4,000 | $2,000 | $2,000 | $2,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $0 | $565,000 | $833,000 | $1,267,000 |
| Current Capital Lease Obligation | $0 | $268,000 | $434,000 | $394,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $3,160,000 | $64,000 | $3,081,000 | $5,463,000 |
| Current Accrued Expenses | $10,442,000 | $14,583,000 | $11,225,000 | $9,459,000 |
| Net PPE | $3,000 | $7,633,000 | $5,971,000 | $2,030,000 |
| Accumulated Depreciation | $-374,000 | $-463,000 | $-270,000 | $-101,000 |
| Gross PPE | $377,000 | $8,096,000 | $6,241,000 | $2,131,000 |
| Leases | $0 | $133,000 | $129,000 | $129,000 |
| Construction In Progress | $0 | $6,590,000 | $4,389,000 | $77,000 |
| Machinery Furniture Equipment | $377,000 | $535,000 | $529,000 | $403,000 |
| Buildings And Improvements | $0 | $787,000 | $1,169,000 | $1,522,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $0 | $1,778,000 | $421,000 | $917,000 |
| Work In Process | $0 | $0 | $1,366,000 | $0 |
| Raw Materials | $0 | $3,533,000 | $4,640,000 | $944,000 |
| Other Short Term Investments | $108,129,000 | $18,567,000 | $45,957,000 | $133,541,000 |
| Other Properties | - | $51,000 | $25,000 | $1,522,000 |
| Dueto Related Parties Non Current | - | - | $0 | $5,757,000 |
| Dueto Related Parties Current | - | - | $5,757,000 | $0 |
Fetched: 2026-05-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-97,985,000 | $-61,204,000 | $-63,635,000 | $-50,084,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-97,433,000 | $-59,550,000 | $-59,663,000 | $-49,640,000 |
| Cash Flow From Continuing Operating Activities | $-97,433,000 | $-59,550,000 | $-59,663,000 | $-49,640,000 |
| Operating Gains Losses | $-87,266,000 | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-552,000 | $-1,654,000 | $-3,972,000 | $-444,000 |
| Investing Cash Flow | $11,891,000 | $25,202,000 | $83,206,000 | $-132,886,000 |
| Cash Flow From Continuing Investing Activities | $11,891,000 | $25,202,000 | $83,206,000 | $-132,886,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $100,002,000 | $0 | $0 | $72,500,000 |
| Financing Cash Flow | $94,376,000 | $130,000 | $326,000 | $72,620,000 |
| Cash Flow From Continuing Financing Activities | $94,376,000 | $130,000 | $326,000 | $72,620,000 |
| Net Other Financing Charges | $-5,701,000 | $-16,000 | $-160,000 | $-659,000 |
| Net Common Stock Issuance | $100,002,000 | $0 | $0 | $72,500,000 |
| Common Stock Issuance | $100,002,000 | $0 | $0 | $72,500,000 |
| Cash Dividends Paid | - | - | - | $0 |
| Other | ||||
| Interest Paid Supplemental Data | $0 | $211,000 | $230,000 | $230,000 |
| End Cash Position | $37,568,000 | $28,734,000 | $62,952,000 | $39,083,000 |
| Beginning Cash Position | $28,734,000 | $62,952,000 | $39,083,000 | $148,989,000 |
| Changes In Cash | $8,834,000 | $-34,218,000 | $23,869,000 | $-109,906,000 |
| Proceeds From Stock Option Exercised | $75,000 | $146,000 | $486,000 | $779,000 |
| Net Investment Purchase And Sale | $-88,843,000 | $26,856,000 | $87,178,000 | $-132,442,000 |
| Sale Of Investment | $59,845,000 | $63,338,000 | $151,617,000 | $12,750,000 |
| Purchase Of Investment | $-148,688,000 | $-36,482,000 | $-64,439,000 | $-145,192,000 |
| Net Business Purchase And Sale | $101,286,000 | $0 | - | $0 |
| Sale Of Business | $101,286,000 | $0 | - | $0 |
| Net PPE Purchase And Sale | $-552,000 | $-1,654,000 | $-3,972,000 | $-444,000 |
| Purchase Of PPE | $-552,000 | $-1,654,000 | $-3,972,000 | $-444,000 |
| Change In Working Capital | $1,930,000 | $-6,050,000 | $-3,404,000 | $-1,820,000 |
| Change In Other Current Liabilities | $-291,000 | $-310,000 | $-502,000 | $-291,000 |
| Change In Other Current Assets | $-438,000 | $518,000 | $518,000 | $437,000 |
| Change In Payables And Accrued Expense | $3,923,000 | $-9,773,000 | $-132,000 | $3,220,000 |
| Change In Prepaid Assets | $-434,000 | $2,814,000 | $3,603,000 | $-1,463,000 |
| Change In Inventory | $170,000 | $1,116,000 | $-3,265,000 | $-1,861,000 |
| Change In Receivables | $-1,000,000 | $-415,000 | $-3,626,000 | $-1,862,000 |
| Changes In Account Receivables | $-1,000,000 | $-415,000 | $-3,626,000 | $-1,862,000 |
| Other Non Cash Items | $74,000 | $460,000 | $519,000 | $382,000 |
| Stock Based Compensation | $9,873,000 | $10,839,000 | $11,954,000 | $9,643,000 |
| Amortization Of Securities | $-1,527,000 | $-1,301,000 | $-3,136,000 | $-1,215,000 |
| Depreciation Amortization Depletion | $79,000 | $193,000 | $169,000 | $159,000 |
| Depreciation And Amortization | $79,000 | $193,000 | $169,000 | $159,000 |
| Gain Loss On Sale Of Business | $-87,266,000 | - | - | - |
| Net Income From Continuing Operations | $-20,596,000 | $-63,691,000 | $-65,765,000 | $-60,513,000 |
| Asset Impairment Charge | - | - | $0 | $3,724,000 |
| Purchase Of Business | - | - | - | $0 |
| Unrealized Gain Loss On Investment Securities | - | - | - | $0 |
| Issuance Of Debt | - | - | - | - |
| Net Issuance Payments Of Debt | - | - | - | - |
| Net Long Term Debt Issuance | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
| Change In Payable | - | - | - | - |
| Change In Account Payable | - | - | - | - |
Fetched: 2026-05-23